A High-Speed Congenic Strategy Using First-Wave Male Germ Cells

• Narumi Ogonuki,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Kimiko Inoue,

  Affiliations RIKEN BioResource Center, Tsukuba, Ibaraki, Japan, Graduate School of Life and Environmental Science, University of Tsukuba, Tsukuba, Ibaraki, Japan

  ⨯
• Michiko Hirose,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Ikuo Miura,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Keiji Mochida,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Takahiro Sato,

  Affiliations Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan, Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Company Limited, Tsukuba, Ibaraki, Japan

  ⨯
• Nathan Mise,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Kazuyuki Mekada,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Atsushi Yoshiki,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Kuniya Abe,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Hiroki Kurihara,

  Affiliation Department of Physiological Chemistry and Metabolism, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯
• Shigeharu Wakana,

  Affiliation RIKEN BioResource Center, Tsukuba, Ibaraki, Japan

  ⨯
• Atsuo Ogura

  * E-mail: ogura@rtc.riken.go.jp

  Affiliations RIKEN BioResource Center, Tsukuba, Ibaraki, Japan, Graduate School of Life and Environmental Science, University of Tsukuba, Tsukuba, Ibaraki, Japan, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan

  ⨯